New patent for Glaxosmithkline drug ARNUITY ELLIPTA

Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…

Source


Comments are closed.

Biotechblog